A recent study shows that ABT-263 is able to eliminate senescent cells strongly expressing BCL-2 and BCL-xL proteins in a mouse multipotent hematopoietic progenitor cell model where LCH lesions contain the BRAFV600E mutation (66). Here, BCL2 is linked to Langerhans cell histiocytosis.